BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16403024)

  • 1. Factor VIIIa regulates substrate delivery to the intrinsic factor X-activating complex.
    Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
    FEBS J; 2006 Jan; 273(2):374-87. PubMed ID: 16403024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrophorin-2: a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex.
    Zhang Y; Ribeiro JM; Guimarães JA; Walsh PN
    Biochemistry; 1998 Jul; 37(30):10681-90. PubMed ID: 9692958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane.
    Ahmad SS; Walsh PN
    Biochemistry; 2005 Oct; 44(42):13858-65. PubMed ID: 16229474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
    Ahmad SS; London FS; Walsh PN
    J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
    Ahmad SS; Scandura JM; Walsh PN
    J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies.
    Scheiflinger F; Dockal M; Rosing J; Kerschbaumer RJ
    J Thromb Haemost; 2008 Feb; 6(2):315-22. PubMed ID: 18088341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
    London F; Walsh PN
    Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between residues 2228-2240 within factor VIIIa C2 domain and factor IXa Gla domain contribute to propagation of clot formation.
    Soeda T; Nogami K; Ogiwara K; Shima M
    Thromb Haemost; 2011 Nov; 106(5):893-900. PubMed ID: 21947241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human factor VIIIa by anti-A2 subunit antibodies.
    Lollar P; Parker ET; Curtis JE; Helgerson SL; Hoyer LW; Scott ME; Scandella D
    J Clin Invest; 1994 Jun; 93(6):2497-504. PubMed ID: 8200986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
    Fang H; Zögg T; Brandstetter H
    FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor IX Denver, ASN 346-->ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interaction.
    Lefkowitz JB; Nuss R; Haver T; Jacobson L; Thompson AR; Manco-Johnson M
    Thromb Haemost; 2001 Sep; 86(3):862-70. PubMed ID: 11583320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation.
    Fribourg C; Meijer AB; Mertens K
    Biochemistry; 2006 Sep; 45(35):10777-85. PubMed ID: 16939230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.
    Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ
    J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
    Wilkinson FH; Ahmad SS; Walsh PN
    J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the NH2-terminal EGF-domain of factor IXa to the specificity of intrinsic tenase.
    Qureshi SH; Yang L; Rezaie AR
    Thromb Haemost; 2012 Dec; 108(6):1154-64. PubMed ID: 23014580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.